Advances in Personalized Diagnosis and Treatment of Ophthalmic Diseases
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Methodology, Drug and Device Discovery".
Deadline for manuscript submissions: 10 June 2024 | Viewed by 232
Special Issue Editor
2. Department of Ophthalmology, Tufts University School of Medicine, Boston, MA 02111, USA
3. Graduate Faculty, The New England College of Optometry, Boston, MA 02215, USA
Interests: ophthalmology
Special Issue Information
Dear Colleagues,
The Journal of Personalized Medicine is pleased to announce a Special Issue on "Advances in Personalized Diagnosis and Treatment of Ophthalmic Diseases". This Special Issue aims to showcase cutting-edge research, innovative approaches, and significant developments in the field of personalized medicine applied to ophthalmology.
For this Special Issue, we invite original research, commentaries, and reviews that explore various aspects of personalized approaches in ophthalmology. The scope of the Special Issue includes, but is not limited to, the following topics:
- Integration of genetic, molecular, and imaging biomarkers for individualized disease risk assessment and precise diagnosis;
- Innovative diagnostic imaging techniques and technologies for improved disease characterization to improve patient outcomes in ophthalmic diseases;
- Role of artificial intelligence and machine learning in personalized ophthalmology;
- Digital health technologies for remote monitoring and personalized disease management for teleophthalmology;
- Individualized drug delivery systems or treatment paradigms for enhanced treatment outcomes;
- Social and policy implications of personalized medicine in ophthalmology.
By contributing to this Special Issue, authors will have the opportunity to showcase their work in an international, peer-reviewed, open access journal that emphasizes the translation of personalized medicine principles into clinical practice. JPM offers a rapid review process and high visibility, ensuring that accepted manuscripts reach a wide readership.
Dr. David Ramsey
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- personalized ophthalmology
- ophthalmic imaging
- biomarkers
- artificial intelligence
- digital health
